These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 11745408)
1. Inhibition of neuroblastoma-induced angiogenesis by fenretinide. Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408 [TBL] [Abstract][Full Text] [Related]
2. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma. Raguénez G; Mühlethaler-Mottet A; Meier R; Duros C; Bénard J; Gross N BMC Cancer; 2009 Mar; 9():97. PubMed ID: 19331667 [TBL] [Abstract][Full Text] [Related]
3. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537 [TBL] [Abstract][Full Text] [Related]
4. BBC3 mediates fenretinide-induced cell death in neuroblastoma. Wei JS; Whiteford CC; Cenacchi N; Son CG; Khan J Oncogene; 2005 Dec; 24(54):7976-83. PubMed ID: 16091745 [TBL] [Abstract][Full Text] [Related]
5. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth. Furumatsu T; Nishida K; Kawai A; Namba M; Inoue H; Ninomiya Y Int J Cancer; 2002 Jan; 97(3):313-22. PubMed ID: 11774282 [TBL] [Abstract][Full Text] [Related]
6. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors. Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518 [TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma. Di Paolo D; Pastorino F; Zuccari G; Caffa I; Loi M; Marimpietri D; Brignole C; Perri P; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M; Pagnan G J Control Release; 2013 Sep; 170(3):445-51. PubMed ID: 23792118 [TBL] [Abstract][Full Text] [Related]
9. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. Ribatti D; Nico B; Morbidelli L; Donnini S; Ziche M; Vacca A; Roncali L; Presta M J Vasc Res; 2001; 38(4):389-97. PubMed ID: 11455210 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma. Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Montaldo PG; Gambini C; Allen TM; Bogenmann E; Ponzoni M Int J Cancer; 2003 May; 104(5):559-67. PubMed ID: 12594810 [TBL] [Abstract][Full Text] [Related]
11. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells. Mangieri D; Nico B; Coluccia AM; Vacca A; Ponzoni M; Ribatti D Cancer Lett; 2009 May; 277(2):199-204. PubMed ID: 19150583 [TBL] [Abstract][Full Text] [Related]
12. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo. Ribatti D; Alessandri G; Vacca A; Iurlaro M; Ponzoni M Int J Cancer; 1998 Jul; 77(3):449-54. PubMed ID: 9663609 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799 [TBL] [Abstract][Full Text] [Related]
14. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979 [TBL] [Abstract][Full Text] [Related]
15. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice. Bäckman U; Christofferson R Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Haspel HC; Scicli GM; McMahon G; Scicli AG Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976 [TBL] [Abstract][Full Text] [Related]